MediWound (MDWD) Non-Current Assets (2016 - 2026)
MediWound (MDWD) posted Non-Current Assets of $28.9 million for Q2 2026, up 4.0% on a QoQ basis from $27.8 million in Q1 2026, and up 20.93% year-over-year from $23.9 million in Q2 2025.
Analysis
MediWound (MDWD) Non-Current Assets (2016 - 2026) Analysis & Trends
MediWound has reported Non-Current Assets for 11 years, with the latest figure at $28.9 million in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 20.93% year-over-year to $28.9 million in Q2 2026; TTM through Jun 2026 was $107.9 million, a 22.51% increase from a year earlier, with the FY2025 full-year figure at $26.3 million, up 23.24% from the prior year.
- Non-Current Assets was $28.9 million for Q2 2026 at MediWound, up from $27.8 million in the prior quarter.
- The five-year high for Non-Current Assets was $28.9 million in Q2 2026, with the low at $4.1 million in Q3 2022.
- Average Non-Current Assets over 5 years is $16.3 million, with a median of $19.1 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets declined 12.85% in 2022, then jumped 301.44% in 2023.
- Over 5 years, Non-Current Assets stood at $4.2 million in 2022, then surged by 301.44% to $16.8 million in 2023, then climbed by 27.25% to $21.3 million in 2024, then gained by 23.24% to $26.3 million in 2025, then climbed by 10.03% to $28.9 million in 2026.
- The last three Non-Current Assets figures came in at $28.9 million (Q2 2026), $27.8 million (Q1 2026), and $26.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.15 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 564.41 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | 28.93 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.93 Mn |
| Mar 31, 2026 | 27.82 Mn |
| Dec 31, 2025 | 26.29 Mn |
| Sep 30, 2025 | 24.89 Mn |
| Jun 30, 2025 | 23.92 Mn |
| Mar 31, 2025 | 21.99 Mn |
| Dec 31, 2024 | 21.33 Mn |
| Sep 30, 2024 | 20.85 Mn |
| Jun 30, 2024 | 19.98 Mn |
| Mar 31, 2024 | 18.18 Mn |
| Dec 31, 2023 | 16.76 Mn |
| Sep 30, 2023 | 13.77 Mn |
| Jun 30, 2023 | 6.31 Mn |
| Mar 31, 2023 | 5.40 Mn |
| Dec 31, 2022 | 4.18 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 4.41 Mn |
| Dec 31, 2021 | 4.79 Mn |
| Sep 30, 2021 | 4.50 Mn |